Palvella Therapeutics
Price & Volume
Stats
See more52W Range | $72.22-$161.38 |
Market Cap | $2.1B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$4.85 |
News
See moreYahoo Finance • 14 days ago
William Blair Expands Biotech Research as Veteran Analyst Alethia Young Initiates Coverage
Yahoo Finance • 2 months ago
Ligand Pharmaceuticals Highlights XOMA-Fueled Royalty Growth, $700M in Deployable Capital
Yahoo Finance • 3 months ago
Palvella Therapeutics to Host Second Quarter 2026 Financial Results and Corporate Update Conference Call on August 4, 2026
Yahoo Finance • 4 months ago
Palvella Therapeutics (PVLA) Submits Initial Module of NDA For QTORIN
About
CEO | Mr. Wesley H. Kaupinen |
CFO | Mr. Matthew E. Korenberg |
Address | 353 W. Lancaster Avenue, Wayne, PA, United States, 19087 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 29 |